Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Open in API
Filings indexed 1,550 across all filing types
Latest filing 2022-11-09 Call Transcript
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 70% confidence The document is an invitation and intimation for an earnings call scheduled for Q2 & H1 FY23. It includes details about the conference call, participants, and dial-in information. There are no actual financial statements or substantive financial data presented in the document. The document is primarily an announcement of the earnings call event rather than the earnings release itself or a transcript of the call. Therefore, it fits best under the category of Call Transcript (CT) as it relates to the earnings call event, but since it is only an invitation and not a transcript, the closest appropriate classification is Call Transcript (CT) with moderate confidence.
2022-11-09 English
BODAL CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve Bodal Chemicals Limited has ....
Regulatory Filings
2022-11-07 English
Board Meeting — Financial results/Other business matters
Board/Management Information Classification · 95% confidence The document is a formal notification to stock exchanges about an upcoming Board Meeting scheduled to consider and approve unaudited financial results for the quarter and half year ended 30th September 2022. It also mentions insider trading window closure related to the financial results announcement. The document does not contain any financial data or results itself, but is an announcement of a meeting where such results will be approved. The document length is short (1951 characters) and it serves as an intimation of a board meeting rather than the financial report or results. Therefore, it fits best under Board/Management Information (MANG) as it relates to board meeting notification and management scheduling.
2022-11-07 English
Bodal Chemicals Limited has informed the Exchange about NCLT Order on Amalgamation of S P S Processors Private Limited with Bodal Chemicals Ltd.
Regulatory Filings
2022-11-05 English
Amalgamation/Merger
M&A Activity Classification · 100% confidence The document is a detailed official communication and order from the National Company Law Tribunal (NCLT) regarding the approval of a Scheme of Amalgamation between two companies, including procedural details, approvals, notices, and compliance with regulatory requirements. It includes legal orders, tribunal decisions, and procedural compliance related to a merger/amalgamation. The presence of terms like 'Scheme of Amalgamation', references to Sections 230-232 of the Companies Act, tribunal orders, and detailed procedural steps clearly indicate this is related to merger and acquisition activity. It is not a financial report, earnings release, or regulatory filing of other types. Therefore, the document fits best under the category of M&A Activity (TAR).
2022-11-05 English
General updates
Regulatory Filings Classification · 100% confidence The document is a formal report submitted by Bodal Chemicals Limited to stock exchanges (BSE and NSE) regarding a violation of the company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015. It details a designated person trading shares during a restricted period, the company's investigation, and the disciplinary action taken (a warning letter). The document references SEBI regulations and insider trading rules, and it is a compliance report about insider trading violations. It is not a financial report, earnings release, or management discussion. It is also not an announcement of a report publication but a regulatory compliance filing. Therefore, the document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-11-04 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.